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Abstract
Stem cells  play  a  critical  role  in  tissue  regeneration  and repair,  maintenance  and
turnover and the control of haematopoiesis in the various tissues. These cells have an
incredible ability to differentiate into specific cell types like osteoblasts, chondrocytes
or myocytes and to develop bone, cartilage or muscle tissues. Now it is believed that
the cells do not differentiate by themselves but rather the secretion of the bioactive
(trophic) factors which are responsible for the functional outcome of the tissue. Stem
cells reside in complicated and dynamic three-dimensional (3D) microenvironments in
vivo known as stem cell niches. The niches are composed of extracellular matrix (ECM),
soluble and tethered proteins and supporting cells, which have a profound influence
on the functionality of the cells, including differentiation and trophic factor release. In
this chapter, we review and emphasize the influence of stem cell microenvironment on
the secretion of trophic factors and their perspective application for bone regeneration.
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1. Introduction
Bone is a highly vascularized tissue with an intrinsic property to self-repair, regenerate and
remodel.  It  has an excellent ability to heal traumatic injuries (e.g. fractures) without any
formation of scars. However, there still exist a number of clinical scenarios where their self-
repair and regenerative capabilities fail.  Some of the classic examples include large bone
defects caused by traumatic injury, infection, tumour resection and skeletal abnormalities due
to  congenital  diseases.  Bone-related  injuries  resulting  from these  clinical  scenarios  have
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significant impacts on the health and lifestyle of individuals. In the USA alone, more than half
a million patients experience problems due to bone defects each year, with medical cost
associated with these defects being more than $2.5 billion/annum and this figure is expected
to double by 2020. It is estimated that about 2.2 million bone graft procedures are performed
around the world annually [1–3]. The current strategies used for augmenting bone regenera‐
tion include different bone-grafting methods, such as autologous bone grafts and allografts
[4]. Autologous bone grafts have relatively successful clinical outcomes; however, donor site
morbidity, limited supply and the complicated surgical procedures associated with bone
harvests hinder the efficacy of such procedures. On the other hand, allogenic bone grafts are
excellent in terms of sourcing large quantities of donor tissue required for treating large bone
defects;  however,  the  issues  related  to  immunogenicity,  rejection  reaction  and  disease
transmission render this treatment less ideal [4, 5]. The shortcomings associated with these
treatments have led to exploring tissue engineering approaches and stem cell-based thera‐
pies for bone repair.
There is great promise for stem cell-based therapeutics for the treatment of numerous diseases
and injuries; as such, substantial investment has been made over the past decade for new
therapies. Stem cells play a critical role in tissue regeneration and repair, maintenance,
turnover and the control of haematopoiesis in the bone marrow. They are considered as an
attractive cell population for bone repair due to their proliferation, osteogenic potential and
secretion of potent endogenous trophic factors to enhance local vascularization. These cells
have an incredible ability to differentiate into specific cell types like osteoblasts, chondro‐
cytes or myocytes and to develop bone, cartilage or muscle tissues. It is believed that the stem
cells can help in repairing the damaged tissue not only by direct differentiation process but
also indirectly through the secretion of their bioactive (trophic) factor [6]. In case of any tissue
damage, the stem cells can be attracted to the damage site wherein they secrete bioactive factors
that can function to trophically assist the repair and regeneration process.
In this chapter, we discuss about the (1) role of the stem cells in bone regeneration and their
trophic factors and (2) the influence of stem cell microenvironment on the secretion of trophic
factors and their effects on bone regeneration. The stem cell-based therapies using trophic
factors may have profound clinical applications.
2. Stem cells and bone regeneration
Bone regenerates through complex and organized biological events of bone induction and
conduction. This process involves a number of cell types and molecular signalling pathways
in a defined sequence to maximize the repair and regeneration of the skeletal tissue. The
organic matrix of the bone tissue is composed of collagen type I fibres (approximately 95%)
proteoglycans and numerous non-collagenous proteins (5%) [7]. Non-collagenous proteins
participate in the process of matrix maturation, mineralization and may regulate the func‐
tional activity of bone cells. Primarily, the functional integrity of bone tissue is maintained by
the cell types such as osteoblasts (bone-forming cells) and osteoclasts (bone-resorbing cells).
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During the phase of bone formation, the osteoblasts are recruited from mesenchymal stem
cells (MSCs) present in bone marrow [8]. On the other hand, osteoclasts are derived from
haematopoietic stem cells through committed osteoclast progenitors that fuse to form mature
multinucleated cells [9]. The regeneration process occurs through osteogenesis initiated by
skeletal stem cell also known as mesenchymal stem cells. During embryogenesis, the devel‐
opment of the skeletal tissue occurs by intramembranous and endochondral ossification. Bone
formations begin with aggregation of MSCs to form condensations and within the mesenchy‐
mal condensation core; cells differentiate into chondrocytes in endochondral ossification or
directly into osteoblasts in the intramembranous bone formation pathway [10]. Therefore, stem
cells play a key role in bone regeneration and are considered to have the potential to treat bone
defects either through cell-based therapies or tissue engineering. Stem cell-mediated bone
regeneration provides a number of potential therapeutic advantages as compared to the use
of autograft tissues. As such, therapeutic uses of stem cells are being explored extensively for
bone tissue regeneration applications. MSCs and adipose-derived stem cells (ADSCs) have
received considerable attention in this regard and have been extensively evaluated for bone
regeneration.
Numerous studies in animal models clearly demonstrate that stem cells have the potential to
treat critical-sized segmental defects, mandibular defects and effective spinal fusion to name
a few. More recently, Liu et al. showed that systemic injection of MSCs into mandibular defects
of dogs can increase new bone formation as compared to the defect without any cells [11].
Some clinical reports also suggest that MSCs and ADSCs can be used for treating fractures of
the distal tibia, osteonecrosis of the femoral head and maxillary defects [12–16]. Although these
results are promising, the efficacy of translating these outcomes into clinical practice at a large
scale is still in infancy.
In addition to the cell-based therapies, stem cells are combined with biomaterials and im‐
planted into the defect site and this tissue engineering approach is considered to be a prom‐
ising strategy to treat bone defects. Numerous small animal studies have shown that treating
the bone defects with a combination of biomaterials and MSCs can augment bone regenera‐
tion. Human bone marrow MSCs and macroporous calcium phosphate cement were com‐
bined and transplanted into critical-sized cranial defects in rats. The constructs generated
much more new bone and blood vessels than the control calcium phosphate cement without
cells [16]. Porous tantalum rods were implanted with or without autologous bone marrow
stromal cells (BMSCs) on hind legs in dogs and the scaffold combined with cells enhanced new
bone formation after 12 weeks of implantation [17]. These studies indicate that the combina‐
tion of scaffolds with stem cells can enhance bone regeneration to greater extent. Likewise,
composite scaffolds consisting of polycaprolactone and tricalcium phosphate (TCP) com‐
bined with autologous MSCs or recombinant human bone morphogenetic protein 7 was trans‐
planted into critical-sized defects of the long bones of the sheep. The composite scaffold loaded
with growth factor and MSCs was able to induce enhanced bone formation, indicating the
importance of soluble factor in effective bone regeneration [18]. The osteogenic capability of
ADSCs cells in healing critical-size mouse calvarial defects showed that implantation of apa‐
tite-coated poly lactic-co-glycolic acid scaffolds seeded with ADSCs can heal critical-size skel‐
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etal defects without genetic manipulation or the addition of exogenous growth factors [19, 20].
These animal studies with a combination of scaffolds and stem cells have shown great prom‐
ise with excellent bone regeneration capabilities; however, translation of these into clinical use
is limited. A study by Kawate et al. used a tissue engineering approach and transplanted β-
TCP with MSCs and a free vascularized fibula into three young patients with steroid-in‐
duced osteonecrosis of the femoral head. Two out of the three patients showed healing of the
defect with new bone formation and vascularization within 27 months of implantation.
Although these studies with a tissue engineering approach was promising, problems still
persist in terms of validating the source of the stem cells, the safety, the cost involved and more
importantly understanding the molecular mechanisms involved and these questions has to be
addressed before any clinical application can be achieved [21].
3. Stem cell trophic factors
In the recent past, stem cell technology has revolutionized the field of regenerative medicine
and has been an attractive platform for the purposes of tissue repairs and cancer treatments.
Stem cells are ideal for regenerative purposes due to their multipotentiality and self-renew‐
ing capabilities and this concept is fairly well established through many in vitro, in vivo and
preclinical studies [22]. These cells play important roles in many biological processes, includ‐
Figure 1. Various paracrine factors released by mesenchymal stem cells which play an important role in mitogenesis,
angiogenesis, apoptosis and scarring. Endothelial Growth Factor (EGF), Fibroblast Growth Factor (FGF), Hepatocyte
Growth Factor (HGF), Insulin Growth Factor (IGF), Kerotinocyte growth factor (KGF ), Macrophage Inflammatory
Proteins (MIP), Secreted Frizzled-Related Protein 2, Stanniocalcin-1(STC-1), Stromal cell derived factor (SDF), Trans‐
forming Growth Factor (TGF), Vascular Endothelial Growth Factor (VEGF).
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ing anti-inflammation, cell migration, proliferation and differentiation, and signal pathway
activation or inhibition. There is strong understanding that stem cells (especially MSCs) are
able to repair the tissue by modulating the environment they reside, influencing the im‐
mune response, supporting angiogenesis, and also through the productive cross talk with the
resident cells as illustrated in schematic diagram (Figure 1). It is believed that the stem cells
may be able to achieve these activities through the secretion of a broad panel of biomole‐
cules called as trophic factors including growth factors, cytokines and chemokines and also
the factors released in the extracellular vesicles (exosomes and microvesicles) [23–25]. There‐
fore, in recent years, researchers have a notion that the secret to the stem cell-based therapy
may lie in the stem cell-secreted biomolecules rather than the cell itself as a therapeutic tool.
Hence, there is a curious enthusiasm to explore and understand more about these secretion
factors in order to enable a switch from use of stem cells to the use of stem cell secretion factors
in regenerative medicine [22, 26]. MSCs are reported to secrete a variety of trophic factors such
as transforming growth factors (TGF-α and β), hepatocyte growth factor (HGF), epithelial
growth factor (EGF), basic fibroblast growth factor (FGF-2), insulin-like growth factor-1
(IGF-1), and vascular endothelial growth factor (VEGF) which induces mitogenesis and an‐
giogenesis and are also anti-apoptotic. Other trophic factors like interleukins, stromal cell-
derived factor-1 and prostaglandin 2 are the key immunomodulatory cytokines [6, 25, 27, 28]
as illustrated in Figure 2. Some fundamental studies have demonstrated that administration
of stem cell condition medium containing bioactive factors released by the cells in culture
medium can exert regenerative properties. Stem cell-derived secretory molecules has shown
some promising tissue-repairing properties in cardiovascular [29], renal [6, 30], liver [31], lung
injury [32], and neurodegenerative disease models [22, 33]. Trophic factors secreted by MSCs
have induced proliferation of endogenous cardiac progenitor cells in vitro. Nakanishi et al.
highlighted that conditioned media from rat MSCs can promote proliferation and migration
of isolated cardiac progenitor cells and prevent their apoptosis when subjected to hypoxia and
serum starvation [34]. Furthermore, human MSC secretions harvested in conditioned medi‐
um, reduced infarct size and preserved cardiac function in a large animal model of myocar‐
dial infarction [35]. MSC-conditioned media harvested after 24 h enhanced the paracrine effect
and prevented oxygen-induced neonatal lung injury in a rat model [36]. An interesting study
by Du et al. showed that MSC-conditioned media could even protect hepatocytes and sinus‐
oidal endothelial cells and stimulate their regeneration in reduced-size rat liver transplanta‐
tion [37]. The outcomes of this work was well complemented by another study undertaken by
Van Poll et al., who provided clear evidence that introduction of MSC-conditioned media in
a D-galactosamine-induced rat model of acute liver injury could enhance proliferation of hep‐
atocytes and reduce apoptotic hepatocellular death, thereby increasing the survival rates and
preventing hepatic failures [38]. The role of trophic factors in the treatment of chronic kid‐
ney disease is well demonstrated by Koppen et al. in a rat model. This study showed that
administration of human embryonic MSC-conditioned media decreases the progression of
chronic kidney disease with reduced hypertension and glomerular injury indicating the ther‐
apeutic benefits of trophic factors for kidney-related injuries and disease [39]. Most of the
investigators have shown the beneficial effects of trophic factors from MSCs; however, it is not
just confined to these cells alone. Adipose-derived stem cells which are also gaining popular‐
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ity as an attractive source of cells for regenerative purposes is showing similar properties. Sowa
et al. showed that growth factors from ADSCs can promote peripheral nerve regeneration
through paracrine secretion of trophic factors regardless of donor age or anatomic site of origin.
The effects of mouse ADSCs-conditioned medium were tested on Schwann cells and dorsal
root ganglion neurons in vitro. The results showed that ADSCs produced factors which were
capable of promoting survival and proliferation of Schwann cells and enhancing the neurite
outgrowth in dorsal root ganglion neurons in vitro [40]. Yamada et al. showed that ADSC-
secreted molecules could induce a trophic effect in pancreatic islet culture conditions in vitro.
These results suggested that trophic factors, particularly VEGF, secreted by human ADSCs
enhanced the survival and function of porcine islet cells [41]. These studies suggest that the
stem cell trophic factors alone have the potential for therapeutic use and can enhance effects
in regeneration. The concept of utilizing the stem cell secretome for tissue repair is undoubt‐
edly a step forward towards cell-free regenerative medicine and the effect of trophic factors in
many other types of tissues like bone, ligament and for wound healing purposes is being
explored.
Figure 2. Architecture of the stem cell niche consisting of extracellular matrix, support cells, soluble trophic factors,
transmembrane cell adhesion molecules and progenitor cells.
4. Stem cell trophic factors for bone regeneration
So far the use of stem cells in bone regeneration has largely been focussed on either trans‐
planting the stem cells directly to the defect site or through the tissue engineering ap‐
proaches. However, in recent years, the paracrine effects of stem cells in bone regeneration are
being extensively explored and this can have positive implications in the field of bone
regeneration. The secretion factors of the stem cells (e.g. MSCs) may have potential therapeu‐
tic applications in rheumatoid arthritis, osteoarthritis, genetic bone and cartilage disorders as
well as bone metastasis [42]. The secretion factors released from the MSCs during their,
osteogenic differentiation process induce recruitment and differentiation of endogenous
progenitors. Murine MSCs was cultured in osteogenic medium and the condition media was
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collected and assessed for its effects on differentiation and migration of exogenous MSCs. The
results showed that MSCs maintained in osteogenic medium, secreted factors at specific time
points that induced alkaline phosphatase activity in exogenous MSCs as well as their migra‐
tion thus showing the important contribution of trophic factors in the process of bone repair
[43]. A study by Ando et al. showed that MSC-derived trophic factors can accelerate the healing
process in distraction osteogenesis. In this study, serum-free conditioned medium derived
from human MSCs was locally administered into the distraction gap in a high-speed distrac‐
tion osteogenesis mouse model. The introduction of the MSC condition media supported the
recruitment of murine bone marrow stromal cells and endothelial promoting osteoblast
proliferation, differentiation and angiogenesis [44]. The role of trophic factors in treating
rheumatoid arthritis is well demonstrated by Ishikawa et al. using dental pulp stem cells
(DPSCs). This study showed that delivery of serum-free conditioned media from DPSCs into
a collagen type II antibody-induced arthritis mouse model of the rheumatoid arthritis can
inhibit inflammation-induced M2-type conditions I and suppress osteoclastogenesis and bone
destruction in collagen type II antibody-induced arthritis [45]. An excellent study by Doorn et
al. showed that trophic factors from human MSCs can contribute immensely to bone forma‐
tion. In this study, human MSCs (hMSCs) were treated with small molecule dibutyryl cyclic
adenosine monophosphate (db-cAMP) and the condition media was collected. This was used
to culture a variety of cells including human umbilical vein endothelial cells, osteosarcoma,
breast cancer and mouse myoblast cell line. The treatment of the condition media from cAMP-
treated hMSCs to various cells could improve their proliferation and induce osteogenic
differentiation with differential effects on migration. This study indicated that the trophic
factors secreted by hMSCs can be tuned for a specific application [26, 46]. An in vitro study to
investigate the role of brain-derived neurotrophic factor (BDNF) in spinal cord repair has
shown that the condition media with the increased levels of BDNF was able to protect the
motoneurons and enhance its survival rate, thus indicating the therapeutic benefits the trophic
factors can have in the treatments of spinal cord injuries [47].
Furthermore, Cantinieaux et al. also showed the paracrine-mediated actions of bone marrow
stromal cells for treating spinal cord injuries. An in vitro and in vivo study was conducted to
evaluate the effects of factors released by the bone marrow stromal cells in a spinal cord injury
in a rat model. The in vitro studies showed that bone marrow stromal cell-conditioned medium
protected the neurons from apoptosis, activated macrophages and also exhibited some
proangiogenic properties. Similar beneficial effects of trophic factors from the bone marrow
stromal cells condition was also observed in the in vivo studies with histological analysis
showing the proangiogenic action and tissue protection effect [48].
In addition, the effect of secretion factors from human umbilical cord-derived mesenchymal
stem cells on the osteogenesis of human MSCs has shown to initiate osteogenic differentia‐
tion with increased amount of calcium deposit, and upregulation of osteogenic gene expres‐
sion [49]. These outcomes suggests that stem cell trophic factors may have key solutions for
bone repair and regenerations and further mechanistic understanding can reveal their
potential for further clinical applications.
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5. Stem cell microenvironment: biophysical cues and trophic factors
Stem cells reside in complicated and dynamic three-dimensional (3D) microenvironments in
vivo known as stem cell niches where they undergo self-renewal and differentiation. Their
function is maintained through an array of complex signals derived from this niche [50–52].
Structurally, the niche is composed of extracellular matrix (ECM), soluble proteins like
chemokines, cytokines and growth factors, supporting cells and physical factors. [53, 54]. ECM
proteins are the influential components of the niche and they primarily help in maintaining
stem cell homoeostasis and direct lineage commitment. ECM forms the vital communication
network for transferring the cell signals emanated from soluble and matrix-bound factors and
from cell-matrix interactions and the composition of the ECM can govern the fate of the cells
considerably [55–57]. This concept is very well demonstrated through the preservation of the
decellularized matrix which was able to guide stem cell differentiation into the cell types
residing in the tissue from which the ECM was derived. On the basis of these properties,
decellularized organs have been used in tissue engineering and for developing cell therapy
approaches [58, 59]. ECM parameters are extremely dynamic and are spatially and tempora‐
rily controlled during development suggesting that they play a morphogenetic role in guiding
differentiation and arrangement of cells. Support cells play an important role in restricting the
stem cells to their niche through the cell surface adhesion proteins. The interactions between
the stem cells and the support cells are largely governed by cadherin proteins that form
adherens junctions. As such, stem cells are able to maintain their stemness and self-renewal
when they are in the vicinity of the support cells [60]. Once the cell divides, one daughter cell
remains in contact with the support cell and the other migrates from the niche and commits
itself to a particular lineage [61]. Recent study by Polisetti et al. provided excellent insights
into molecular mechanisms of progenitor cell niche anchorage mediated by integrins-,
cadherins- and dystrophin-associated proteins that regulates both stable and dynamic cell-
matrix and cell-cell interactions within the limbal niche [62]. Additionally, support cells such
as perivascular stromal cells including nestin+ mesenchymal stromal cell (MSC) [63], leptin
receptor (Lepr) expressing mesenchymal cell and Mx1+ stromal cells [64] have shown to play
vital roles in regulating the functions of hematopoietic cells in bone marrow. Support cells such
as osteoblasts were believed to play an important role in preserving the HSCs in a quiescent
state and help in their maintenance or just form a niche supportive of early lymphoid
progenitors [65, 66]. These studies suggest the importance of support cells in the architecture
of stem cell niche which eventually affects the functions of stem cells [67]. Soluble molecules
are another important component of the niche besides ECM and support cells and are
absolutely critical for directing the stem cell fate. Soluble factors can be in the form of growth
factors, cytokines, enzymes, transforming growth factors, bone morphogenic factors and
vitamin C to name a few [68, 69]. These factors can be either added to the culture conditions
or secreted by the stem cells or the supporting cells in the niche. These factors can then bind
to the membrane receptors of the cells and trigger the cell signalling pathways altering the
gene expression of the stem cells [61, 70, 71]. Soluble molecules that are prevalent in most of
the niches include Wnts, hedgehog proteins, FGF and bone morphogenetic proteins (BMP) .
Some of these molecules are key factors in regulating the self-renewal of haematopoietic stem
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cells. It is well established through many studies that Wnts and hedgehog proteins play a key
role in osteogenesis especially in bone formation, maintaining cellular differentiation and
regulating the formation of bone and cartilage, whereas FGFs and BMPs have profound impact
on the osteoprogenitor differentiation and the regulation of the endochondral and intramem‐
branous ossification [60, 72]. Similarly, soluble growth factors and cell membrane-bound
factors such as platelet-derived growth factor (PDGF), TGF-β, VEGF, BMP and Notch
signalling have been implicated as having multivariable effects on cardiac development [73,
74]. In recent years, it has been established that the stem cell niche is not just confined to the
soluble factors and cell-cell interactions but also to the definable physical and mechanical cues,
which influences the decision-making capability of the stem cells. A number of investigators
have demonstrated that stem cells have the ability to sense and transduce the physical and
mechanical cues. The cues such as mechanical strain, stiffness, shear stress and topography
can regulate the fate of the cells. It has been shown that application of mechanical strain can
increase proliferation and decrease differentiation in human embryonic cells, which affects the
cell alignment in the direction of the strain and also directs the MSCs to myogenic pheno‐
type. It has been shown that MSCs can express high levels of ligament-specific markers under
the influence of rotational strain [75–78]. Additionally, the fate of the stem cells can also be
influenced by the substrate stiffness. The effect of stiffness on stem cell differentiation has been
well demonstrated by numerous investigators and an excellent study by Engler et al. showed
that variation in the substrate stiffness can modulate the differentiation of stem cells into
various specific lineages such as neuronal, muscle and osteogenic lineages. This lineage
commitment was found to depend largely on the elasticity of the substrate [53]. A similar result
was highlighted by Saha et al., and Banerjee et al., who showed that changes in the substrate
stiffness can present a defining influence on the differentiation of neural progenitor cells with
stiff substrates modulating the cells to astrocytes while the softer ones towards neuronal
differentiation [79, 80]. Stem cells are also sensitive to the shear stress and this can result in the
morphological changes which in turn affects the cell behaviour at the molecular level. A study
by Illi et al. showed that shear stress can stimulate the molecular pathways leading to histone
modifications in mouse embryonic stem cells resulting in epigenomic regulations [81]. In
addition, the shear stress has been shown to affect the differentiation of stem cells into vascular
cells. Exposure of stem cells to shear stress increased the expression of endothelial cell-specific
markers such as von Willebrand factor and vascular endothelial-cadherin [75]. Topographi‐
cal cues can also influence various behaviours of the stem cells similar to stress, strain and
stiffness. Topographical modifications in the substrate can change the morphological fea‐
tures of the cells which can vary the orientation of the cytoskeletal structure of the cells thus
affecting the function of the stem cell fate. Dalby et al. showed the influence of ordered and
disordered nanoscale pattern on differentiation of MSCs. This study showed that osteogene‐
sis was more predominant with ordered nanoscale pattern with an increase in the expres‐
sion of genes responsible for osteogenic differentiation as compared to the disordered
pattern [82]. A similar outcome was reported by Zouani et al. who showed that substrates with
large nanodepths (100 µm) induced higher osteogenic differentiation as compared to the small
depths (10 µm) indicating that stem cells can sense and respond to the topographical changes
and regulate their function [83–85].
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Such studies have convinced that the mechanical cues can influence the fate of the stem cells;
however, the mechanistic insights as to how these cues direct the differentiation of stem cells
is just beginning to be unravelled. Stem cells can sense the stiff microenvironment and
transduce the signals through the Rho kinase [86, 87], TGF-β [88, 89], Src family kinases [90]
and phosphor-tyrosine signalling pathways [91, 92]. Other studies by Dupont et al. and Swift
et al. have shown that yes-associated protein and transcriptional coactivator with PDZ-binding
motif also have a significant role in regulating the stem cell differentiation mechanism in
response to mechanical parameters. While more and more mechanistic data begins to emerge,
it is only clear that mechanical cues are potent physical parameters in the regulation of stem
cell differentiation [93–96]. The release and beneficial effects of trophic factors from the stem
cells will also depend on the microenvironment it is residing in. Changes in the microenvir‐
onment with respect to the biological and mechanical cues can affect the release of trophic
factors which can have profound implications in their functionality. More studies are now
beginning to emerge to decipher these concepts using various artificial platforms. For example,
Abdeen et al. studied the combined role of stiffness and matrix protein on the secretory profile
of MSCs and their effects on human microvascular endothelial cells. In this work, the condi‐
tioned media from MSCs adherent to polyacrylamide hydrogel with controlled matrix rigidity
and protein composition was collected and applied to a model angiogenesis assay using
HMVECs within Matrigel. The result from this study showed that secretion of the trophic
factors was related to a combined effect of stiffness and adhesion protein for directing
proangiogenic signalling [97]. Jose et al. pretreated the MSCs with glycine-histidine-lysine
(GHK), a peptide fragment of osteonectin and a matrix cellular protein with reported
proangiogenic potential. The study revealed a dose-dependent increase in VEGF concentra‐
tion in media conditioned by GHK-treated MSC, which increased endothelial cell prolifera‐
tion, migration and tubule formation. This study suggested that microenvironment of the stem
cells can have significant influence on the trophic factors and their functionality [98].
Furthermore, Silva et al. showed that the secretome of the bone marrow MSCs were affected
when the cells were cultured on fibronectin peptide-modified hydrogels as compared to the
unmodified gels and this change in the secretome-induced higher metabolic viabilities and
neuronal cell densities [99]. Hoch et al. also showed that cell-secreted decellularized extracel‐
lular matrices can preserve the bone-forming phenotype of the differentiated MSC. In this
study, osteogenically induced MSCs were cultured on the decellularized matrices and the
osteogenic and angiogenic potential was measured after the withdrawal of the induction
media. It was found that culturing osteogenically induced MSCs on decellularized matrix can
enhance calcium deposition and secretion of proangiogenic factor such as VEGF [100].
It has also been noted that the changes in the microenvironment of the stem cells due to
biomolecules can also affect the trophic factors secretion by the stem cells and this can in turn
affect the functionality of the cells by our group and others. We have shown that short-term
exposure of human osteoblasts to tumour necrosis factor (TNF-α) can promote osteogenic
differentiation and also stimulate human osteoblasts to secrete soluble factors that can foster
a microenvironment favouring osteogenic differentiation of ADSC [101]. A similar study was
performed by Czekanska et al., whereby MSCs were stimulated with interleukin-1β (IL1β),
granulocyte-colony stimulating factor (GCSF), stromal cell-derived factor 1 (SDF1) and stem
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cell factor (SCF) for about 2 h. The results showed that a mere 2-h stimulation could affect the
expression of multiple cytokine genes and proteins in MSC significantly. IL1β strongly
promoted the secretion of a wide range of proteins with chemotactic, proinflammatory and
angiogenic properties, whereas SCF regulated the expression of proteins involved in prolifer‐
ation, chondrogenesis and ECM regulation. This outcome was clear evidence that the changes
in secretome can be directed towards a desired final functional outcome through the selec‐
tion of the most appropriate cytokine [102, 103].
Through numerous studies reported in the literature, it is quite evident that the stem cell
function greatly depends on the architecture of the niche; any physical or biochemical
disruption can affect the stem cell function profoundly.
6. Conclusions
Stem cells are in a way considered to be the “building blocks” of regenerative medicine and
are believed to possess solutions to many types of injuries and diseases. Enormous amount of
research is focussed on deciphering and understanding the functionalities of these cells
through the cell-based therapy, through tissue engineering or purely through their para‐
crine activities.
The idea of “stem cell free regenerative” medicine has undoubtedly captured a great deal of
attention in the recent few years. Most studies suggest that the use of stem cells secretory
molecules such as trophic factors, microvesicles or exosomes can be advantageous and
valuable in the treatment of injuries or diseases compared to the cell-based therapies. There
are more to be explored in terms of their mechanisms at a molecular level, the effect of
microenvironment on their release, and the long-term effects of these kinds of treatments in
an in vivo scenario. Answers to these questions can help in validating cell-free regenerative
technology as a potential therapeutic tool.
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